12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Clinical trial NCT02605304 · TERMINATED
Trial details
- NCT number
- NCT02605304
- Sponsor
- Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-17
- Primary completion
- 2017-01-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.